Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma-Reference-Cited by-同舟云学术

Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma

Published:2007-09 Issue:3 Volume:79 Page:234-239
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Murakami Hirokazu,Handa Hiroshi,Abe Masahiro,Iida Sinsuke,Ishii Akihiro,Ishikawa Takayuki,Ishida Tadao,Oota Masatsugu,Ozaki Shuji,Kosaka Masaaki,Sakai Akira,Sawamura Morio,Shimazaki Chihiro,Shimizu Kazuyuki,Takagi Toshiyuki,Hata Hiroyuki,Fukuhara Takashi,Fujii Hiroshi,Miyata Akira,Wakayama Toshio,Takatsuki Kiyoshi

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2007.00908.x/fullpdf

Reference21 articles.

1. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

2. Thalidomide is an inhibitor of angiogenesis.

3. Thalidomide: A novel template for anticancer drugs

4. Bone marrow angiogenesis and progression in multiple myeloma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma;Targeted Oncology;2022-06-30

2. Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients;International Journal of Hematology;2020-09-19

3. Multiple Myeloma: Current Advances and Future Directions;The Kitakanto Medical Journal;2020-08-01

4. Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma;Cancer Science;2018-04-17

5. A multi-targeted approach to treating bone metastases;Bone Cancer;2015